By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – HTG Molecular Diagnostics today said that it will collaborate with Sanofi US on identifying biomarkers that could become a molecular companion diagnostic test.

The potential test would identify patients most likely to respond to an investigational drug being developed by Sanofi.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.